Delivery Order SPE2DB25D3018-SPE2DB25FUYFR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,704.03 on August 19, 2025, for the supply of Sulfamethoxazole-TMP DS tablets (500 count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance based in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order is issued...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,341.68, is for the delivery of sulfamethoxazole-tmp ds tablets to support military healthcare programs. The contract is a firm fixed-price delivery order that runs through April 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,167.36 firm fixed-price delivery order is for 4567794929 SULFAMETHOXAZOLE-TMP DS TABLET 500S, with an ultimate completion date of April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,074.32 firm-fixed-price delivery order contract is for the supply of SULFAMETHOXAZOLE-TMP DS TABLET 100S, with a period of performance running through July 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,326.86 for the delivery of 4565359123 - SULFAMETHOXAZOLE-TMP DS TABLETS 500S. The award has a completion date of August 7, 2024 and is a Firm Fixed Price contract. The contract is not set-aside. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award, which is part of a larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Medical Supply Chain, a component of the Defense Logistics Agency, on July 28, 2025, for the supply of Sulfamethoxazole-TMP DS Tablet in quantities of 100 units. This is a firm fixed price delivery order valued at $1,513.67, with an ultimate completion date of July 29, 2025. The contract is not set-aside and was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,432.78 Firm Fixed Price Delivery Order is for the supply of 4566640994 - Sulfamethoxazole-TMP DS Tablet 100s, with a period of performance through December 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,478.75, is for the delivery of 4567756510 Sulfamethoxazole-TMP DS Tablets in 100-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside and is an open competition award....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for sulfamethoxazole-trimethoprim DS tablets (100-count bottles) valued at $4,627.09. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is executed as a child order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,075.92, is for the provision of 500-count bottles of the antibiotic medication Sulfamethoxazole-TMP DS Tablet. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYFRDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $2,055.66 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-TMP DS tablets (500-count units). This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical vendor supporting federal military and veteran healthcare systems. As a major healthcare solutions provider and pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contract awards covering a broad spectrum of medical products, including brand-name and generic medications, vaccines, and specialized medical supplies. The SPE2DX IDC vehicle enables the company to fulfill diverse pharmaceutical procurement needs across multiple therapeutic domains for customers including the Defense Health Agency and other government healthcare entities, with the Defense Logistics Agency planning future regional pharmaceutical prime vendor contracts potentially involving multiple award recipients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/13/25 |